Clinical trials: COVID19 Patients
Chronic Pain
COVID-19 and Its Effects on Chronic Pain Patients
Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Many factors can affect pain and its severity.
- Trial name
- NCT04715815
- Testing
- No intervention (only interview)
- Volunteers
- 30 people
- Sponsor
- Prince of Songkla University
Pneumonia, Viral
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is complicated by pneumonia (15 to 20% of cases) requiring hospitalization with oxygen therapy.
- Trial name
- COVIDEP (NCT04479540)
- Testing
- Angiography scanner
- Where
- France
- Volunteers
- 117 people
- Sponsor
- Hopital Foch
Smell Dysfunction, Taste Dysfunction
Post-Covid-19 Patients Follow-up Study
Taste, smell, trigeminal and salivary function is impacted in post-COVID-19 patients
- Conditions
- Smell Dysfunction, Taste Dysfunction, Trigeminal Dysfunction, Salivary Dysfunction
- Trial name
- COVID-19 (NCT07571382)
- Testing
- Smell training
- Where
- Norway
- Volunteers
- 176 people, healthy volunteers welcome
- Sponsor
- University of Oslo
Coronavirus Disease 2019, Novel Coronavirus Pneumonia
The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
This is an open-label, randomized, blank-controlled treatment clinical study. The objective of this study is to investigate the effect of T89 on improving oxygen saturation and clinical symptoms in patients with Coronavirus…
- Trial name
- NCT04285190
- Testing
- T89
- Sponsor
- Tasly Pharmaceuticals, Inc.
Loneliness During COVID-19, Loneliness
The Role of Nurses in Video-Based Communication to Reduce Loneliness in Intensive Care Unit Patients
This study aims to evaluate the effectiveness of video-based communication in reducing loneliness among intensive care unit (ICU) patients at Dr. Hasan Sadikin General Hospital in Bandung, Indonesia.
- Trial name
- VBC-ICU (NCT07072078)
- Testing
- Video-based Communication
- Where
- Indonesia
- Volunteers
- 36 people
- Sponsor
- Universitas Padjadjaran
Chronic Liver Disease, Malignant Tumor
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
The goal of this observational study is to explore the influence of Covid-19 infection and risk factors of severe outcomes in vulnerable population including patients with chronic liver disease, malignant tumor, autoimmune…
- Conditions
- Chronic Liver Disease, Malignant Tumor, Autoimmune Diseases, Healthy
- Trial name
- NCT05965843
- Testing
- underling disease
- Volunteers
- 480 people
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
Severe Acute Respiratory Syndrome Coronavirus 2, Metabolic Syndrome
Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
The purpose of this study is to evaluate the efficacy and safety of metformin glycinate at dose of 620 mg twice per day plus standard treatment comparing to standard treatment alone (we will use placebo) of patients who have…
- Conditions
- Severe Acute Respiratory Syndrome Coronavirus 2, Metabolic Syndrome, Type 2 Diabetes
- Trial name
- DMMETCOV19 (NCT04626089)
- Testing
- metformin glycinate
- Where
- Mexico
- Sponsor
- Laboratorios Silanes S.A. de C.V.
Infectious Disease, Pneumonia
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
The research aims to determine the impact of a syndromic mutiplex PCR assay (FilmArray) on the management of patients hospitalized in ICU for severe respiratory disease.
- Conditions
- Infectious Disease, Pneumonia, Molecular Diagnosis, Covid-19
- Trial name
- FAP-REA (NCT04453540)
- Testing
- FilmArray PCR on respiratory samples
- Volunteers
- 150 people
- Sponsor
- Central Hospital, Nancy, France
Covid19, Critical Illness
Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients
Males develop more severe SARS-CoV-2 infection related disease outcome than females. Herein, sex hormones were repeatedly proposed to play an important role in Covid-19 pathophysiology and immunity.
- Trial name
- HAM-SEX-C19 (NCT04979091)
- Testing
- Sex Hormones
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
Covid19, Corona Virus Infection
Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study
Older adults and those with chronic underlying health conditions are the most susceptible to COVID-19 and its complications. Although there has been a rapid response to studying the effects of COVID-19 in the acute stages, little…
- Conditions
- Covid19, Corona Virus Infection, Mobility Limitation, Frailty
- Trial name
- NCT04602260
- Where
- Canada
- Volunteers
- 211 people, healthy volunteers welcome
- Sponsor
- McMaster University
Covid19 Positive Patient, Covid19 Close Contact
Impact Nerium Oleander on Immune Function
Assess the impact of a proprietary extract of Nerium oleander on immune function as evidenced by COVID-19 symptoms and mortality in COVID-19 positive patients and their close contacts compared to controls that did not receive the…
- Conditions
- Covid19 Positive Patient, Covid19 Close Contact, Immune Function
- Trial name
- NCT04486144
- Testing
- Proprietary extract of Nerium oleander
- Where
- United States
- Volunteers
- 82 people
- Sponsor
- HealthQuilt
Covid19
COVID-19 IgG Antibodies in the Serum of Recovered Patients
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in China, in December 2019 and is now spreading worldwide and poses a great…
- Trial name
- NCT04470414
- Testing
- IgG antibodies immunoassay
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Assiut University
COVID-19
Long-Term Respiratory Muscle Strength in Young COVID-19 Patients
The coronavirus disease 2019 (COVID-19) is a highly contagious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- Trial name
- NCT05381714
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Karabuk University
COVID-19, Pneumonia
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
To assess the clinical efficacy of ANG-3777 relative to the standard of care in reducing the severity and progression of pulmonary and renal dysfunction and mortality in adult patients hospitalized with COVID-19 pneumonia
- Trial name
- NCT04459676
- Testing
- Standard of Care (SOC) + ANG-3777
- Where
- 10 sites in Brazil
- Volunteers
- 100 people
- Sponsor
- Angion Biomedica Corp
COVID-19, Lung Cancer
Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019
This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative…
- Conditions
- COVID-19, Lung Cancer, Lung TB, Hemoptysis
- Trial name
- NCT05513248
- Testing
- anatomic lung resection
- Where
- Philippines
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Lung Center of the Philippines
COVID 19
A Simple Approach to Treat COVID-19 Patients at Home.
The newly recognised disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which by early December 2019 had spread from China to the rest of the world, especially Europe, the United…
- Trial name
- COVER (NCT04794998)
- Testing
- Recommended treatment schedule, Control treatment schedule
- Where
- Italy
- Volunteers
- 180 people
- Sponsor
- Mario Negri Institute for Pharmacological Research
Covid19
Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients
This study will evaluate the efficacy of oral Foipan® (camostat mesilate) compared with the current standard of care in reducing the duration of viral shedding of SARS-CoV-2 virus in patients with mild-moderate COVID-19 disease.
- Trial name
- COPS-2003 (NCT04524663)
- Testing
- Camostat Mesilate, Standard of Care Treatment
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Stanford University
COVID-19
Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19
The purpose of this study is to investigate if Quercetin Phytosome is beneficial for the treatment of COVID-19.
- Trial name
- NCT04578158
- Testing
- Standard COVID-19 care, Quercetin Phytosome
- Where
- Pakistan
- Volunteers
- 152 people
- Sponsor
- Liaquat University of Medical & Health Sciences
SARS-CoV2 Infection
Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19)
Primary purpose: To investigate the effect of propolis, a food supplement product, on healing parameters in patients with COVID 19. Secondary purpose: To provide a new supportive treatment in Covid 19 treatment.
- Trial name
- NCT04916821
- Testing
- propolis
- Where
- Turkey (Türkiye)
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- Trabzon Kanuni Education and Research Hospital
COVID-19 Pneumonia
A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia
This is a Phase II, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of MSTT1041A (astegolimab) compared with placebo and of UTTR1147A compared with placebo, in combination with…
- Trial name
- COVASTIL (NCT04386616)
- Testing
- MSTT1041A, UTTR1147A
- Where
- 41 sites in United States, Brazil and 2 more
- Volunteers
- 396 people
- Sponsor
- Genentech, Inc.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.